910 Performance of SNP-based cell-free DNA prenatal screening for 22q11.2 deletion syndrome in a commercial population

Evaluate positive predictive value (PPV) of 22q11.2 deletion syndrome (22q del) with SNP-based prenatal cfDNA screening in a commercial population.

Source: American Journal of Obstetrics and Gynecology - January 1, 2024 Category: OBGYN Authors: Wendy DiNonno, Melissa Maisenbacher, Georgina Goldring, Melda Balcioglu, Kayla Turner, M. Caleb Meads, Kayla Ruiz, Priyanka Arya, Jeffrey Meltzer, Katherine Howard Source Type: research